Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen presentation in virus infection.

N Murray1, A McMichael

  • 1Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.

Current Opinion in Immunology
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National TB cohort review evaluation: insights for control strategies in low-incidence settings.

IJTLD open·2026
Same author

Severity of hair loss and quality of life for patients with central centrifugal cicatricial alopecia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Response to: Impact of potentially inappropriate medications on the risk of hospital admissions and emergency department visits in patients with dementia.

QJM : monthly journal of the Association of Physicians·2024
Same author

Hospital admissions and emergency department visits for people with dementia.

QJM : monthly journal of the Association of Physicians·2023
Same author

Use of real-time immersive digital training and educational technologies to improve patient safety during the processing of reusable medical devices: Quo Vadis?

The Science of the total environment·2023
Same author

Knowledge of Safe Opiate Storage and Disposal in Urology Patients.

Irish medical journal·2022
Same journal

The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases.

Current opinion in immunology·2026
Same journal

Mapping the synovial immune ecosystem in rheumatoid arthritis: cellular cartography and pathotype-guided immune restoration.

Current opinion in immunology·2026
Same journal

Noncanonical ion channel signaling in neurovascular barrier regulation and immune cell trafficking.

Current opinion in immunology·2026
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
See all related articles

Recent advances clarify how cytoplasmic antigens are processed and presented by MHC class I molecules. Studies revealed peptide transporters, refined peptide-MHC interactions, and distinguished antigenicity from immunogenicity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Understanding antigen processing and presentation by Major Histocompatibility Complex (MHC) class I molecules is crucial for adaptive immunity.
  • Cytoplasmic antigens require specific pathways for processing and presentation to T cells.

Purpose of the Study:

  • To summarize recent advances in the understanding of cytoplasmic antigen processing and MHC class I presentation.
  • To highlight key findings regarding peptide transporters, peptide-MHC interactions, and antigenicity versus immunogenicity.

Main Methods:

  • Characterization of peptide transporter-like molecules encoded within the MHC.
  • Transfection studies to correct antigen presentation-mutant cell lines.
  • Crystallographic analysis of HLA A2 and B27 molecules and peptide elution studies.

Related Experiment Videos

  • Studies using transgenic animals to investigate viral antigens.

    • Main Results:

    • Peptide transporter-like molecules encoded by the MHC have been identified and functionally validated.
    • High-resolution crystal structures of HLA A2 and B27 have elucidated peptide-MHC class I interactions.
    • Elution of peptides from MHC molecules provided insights into binding specificities.
    • Transgenic animal models differentiated antigenicity from immunogenicity for viral antigens.

    Conclusions:

    • Significant progress has been made in understanding the molecular mechanisms of antigen processing and presentation.
    • Peptide transporters play a key role in delivering peptides to the MHC class I pathway.
    • Structural and biochemical studies have refined our knowledge of peptide-MHC binding.
    • Distinguishing antigenicity from immunogenicity is vital for vaccine development and immunotherapy.